Clinical trials
Pancreatic Neoplasms clinical trials
Below are recruiting pancreatic neoplasms clinical trials, each written for real people, not researchers. We’re tracking 132 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03711890Recruiting
Advanced imaging to detect early pancreatic cancer during surgery
This study tests a special high-resolution camera that can see tiny details during pancreatic surgery to help doctors detect early-stage pancreatic cancer or precancerous growths called IPMNs. The goal is to improve how well surgeons can identify and remove diseased tissue.
Columbus, OhioAges 18 years+ - NCT06422455Recruiting
Genetic testing for underserved cancer patients
This study offers free genetic testing to cancer patients and their healthcare providers. It aims to help people who may not have easy access to genetic testing understand their cancer risk.
Los Angeles, CaliforniaAges 18 years+ - NCT05714111Recruiting
Registry for pancreatic cancer patients and people being evaluated
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
MilanAges 18 years+ - NCT06016855RecruitingPhase 4
Surgery before radiation therapy for neuroendocrine tumors
This trial tests if removing as much tumor as possible through surgery before a targeted radiation therapy (PRRT) can help people with well-differentiated neuroendocrine tumors that have spread to the liver. The goal is to see if this approach works better than radiation therapy alone.
Nashville, TennesseeAges 18 years+ - NCT05625529Recruiting
Study blood test to detect pancreatic cancer early
This trial studies how well a new blood-based test may help find pancreatic cancer earlier. You may join if you’re an adult who fits a specific risk group and can safely provide a blood sample.
San Diego, CaliforniaAges 18 years+ - NCT06305728Recruiting
New MRI scan and blood tests to find early signs of pancreatic cancer in people with IPMN
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
Basking Ridge, New JerseyAges 18 years+ - NCT04239573Recruiting
Compare pancreatic cyst checkup programs and test markers
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
Birmingham, AlabamaAges 50–75 - NCT06131840RecruitingPhase 1
Study of SGN-CEACAM5C for advanced solid tumors
This trial tests a new drug called SGN-CEACAM5C in people with advanced solid tumors that have not responded to other treatments. The drug targets a protein on cancer cells to try to stop them from growing.
Phoenix, ArizonaAges 18 years+ - NCT06819215RecruitingPhase 1/Phase 2
VB15010 for advanced solid tumors with HRR gene mutation
This trial tests an oral medication (VB15010) in people with advanced solid tumors that have a specific DNA repair gene mutation (called HRR mutation). The goal is to see if the drug can stop or slow down cancer growth.
Jinan, ShandongAges 18–75 - NCT07405099Enrolling by invitation
Pancreas surgery risks in kidney failure patients
This study looks at the risks of pancreas surgery in people with end-stage kidney disease (kidney failure). It aims to help doctors understand how safe these surgeries are for patients on dialysis or with kidney problems.
Ages 20–75 - NCT04370574Recruiting
Testing blood or tissue markers for suspected pancreatic cancer
This trial looks for “soluble biomarkers” (markers that can be found in body fluids like blood) for people who have a pancreatic mass and may have pancreatic ductal adenocarcinoma. The goal is to improve how pancreatic cancer is identified, especially using information taken from an endoscopic ultrasound biopsy.
Montpellier, MontpellierAges 18 years+ - NCT03250078Recruiting
Pancreatic cancer screening for people at high genetic risk
This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.
Norwalk, ConnecticutAges 50–90 - NCT06051695RecruitingPhase 1/Phase 2
CAR T cell therapy for mesothelin-positive solid tumors
This trial tests a new type of immune cell therapy (CAR T-cells) designed to target cancer cells that have a protein called mesothelin but have lost a marker that lets them hide from the immune system. It's for people with advanced solid tumors who have already tried standard treatments.
Gilbert, ArizonaAges 18 years+ - NCT07608055Recruiting
Pancreas Removal and Metabolic Health in Non-Diabetic Patients
This study follows patients who are having part or all of their pancreas removed due to disease. Researchers want to understand how this surgery affects blood sugar control, weight, and overall health in people without diabetes before surgery.
RomeAges 18 years+ - NCT07629960RecruitingPhase 1/Phase 2
New KRAS-Targeting Drug for Advanced Solid Tumors
This early-stage trial tests BLU-924, a new drug designed to target cancer cells with specific KRAS mutations (a common genetic change in pancreatic, lung, and colon cancers). The study aims to find the right dose and see how well it works in patients whose cancers have progressed despite standard treatments.
Sarasota, FloridaAges 18 years+ - NCT07586813RecruitingPhase 2
Romiplostim N01 Plus ATRA for Low Platelets After Gut Cancer
This trial tests a combination of two medicines (Romiplostim N01 and ATRA) to raise dangerously low platelet counts that sometimes persist after chemotherapy for digestive cancers. If your platelets stay low even after previous platelet-raising treatments, this study may help.
BeijingAges 18 years+ - NCT07396662Recruiting
Pancreas Function and Recovery After Surgery
This study looks at how well the pancreas works (both hormone and digestive functions) and what happens to patients after pancreas removal surgery. It may help doctors better predict recovery and long-term health.
Taipei, TaiwanAges 20–75 - NCT06914674RecruitingPhase 2
Tamoxifen for advanced pancreatic SPTP
This trial tests whether tamoxifen, a hormone therapy drug, can shrink or slow down advanced solid pseudopapillary tumors of the pancreas (SPTP) that have estrogen and progesterone receptors. It may be an option for people whose tumors cannot be removed by surgery or have come back after other treatments.
ShanghaiAges 14–80 - NCT06577532RecruitingEarly Phase 1
KRAS mRNA vaccine for advanced solid tumors
This early-phase trial is testing a new mRNA vaccine (ABO2102) designed to target KRAS mutations in advanced solid tumors. It may be an option if your cancer has a KRAS mutation and standard treatments are no longer working.
ShanghaiAges 18 years+ - NCT06953193Recruiting
Comparing anesthesia types for pancreas surgery
This study compares two types of anesthesia for people having pancreatoduodenectomy surgery. It tests whether adding an epidural to general anesthesia can help prevent low blood pressure during the operation.
Mexico City, Mexico CityAges 18 years+ - NCT06685939Enrolling by invitation
Comparing recovery after two types of pancreatic cancer surgery
This study compares two surgeries for pancreatic cancer: laparoscopic (keyhole) pancreaticoduodenectomy and open pancreaticoduodenectomy. It aims to see which approach leads to fewer complications during recovery.
ShanghaiAges 19 years+ - NCT04693754Enrolling by invitation
Collecting results for ultrasound-guided tumor treatment
This trial is a database study that collects information from people who are referred for a procedure using endoscopic ultrasound and heat energy to treat a tumor or enlarged lymph nodes. Your data may help doctors learn how well this treatment works in different situations.
Indianapolis, IndianaAges 14 years+ - NCT01365169Recruiting
How activity level and daily function relate to cancer survival
This study looks at how physical activity (movement during the day) and a clinician-rated “day-to-day function” score relate to overall survival in people with certain cancers. It may help doctors understand who benefits most from activity-focused care and better monitoring.
Houston, TexasAges 18 years+ - NCT07262957RecruitingPhase 4
Preventing complications after pancreatic surgery with a drug bundle
This trial tests whether giving a combination of three treatments—hydrocortisone (a steroid), octreotide (a drug that reduces digestive fluids), and a tissue patch—before and during pancreatic surgery can help prevent complications. It is for people with a very small pancreatic duct (3 mm or less) who are scheduled for pancreatic surgery.
AmsterdamAges 18 years+
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pancreatic neoplasms?
- Yes. Clin2 currently lists 132 recruiting pancreatic neoplasms studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pancreatic neoplasms trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pancreatic neoplasms trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.